RBC Capital Upgrades CVS Caremark (CVS) to Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/31/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts CVS Hot Sheet
Price: $90.25 -0.09%
Rating Summary:
34 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 50 | New: 9
Rating Summary:
34 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 50 | New: 9
Join SI Premium – FREE
RBC Capital upgraded CVS Caremark (NYSE: CVS) from Sector Perform to Outperform, price target raised from $36 to $44.
For more ratings news on CVS Caremark click here and for the rating history of CVS Caremark click here.
Shares of CVS Caremark closed at $38.02 yesterday.
For more ratings news on CVS Caremark click here and for the rating history of CVS Caremark click here.
Shares of CVS Caremark closed at $38.02 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RBC Capital Upgrades Wesfarmers Ltd. (WES:AU) (WFAFF) to Sector Perform
- Freedom Broker Upgrades Mondelez International (MDLZ) to Buy
- Goldman Sachs Upgrades Chow Tai Fook Jewellery Group Ltd. (1929:HK) (CJEWF) to Buy
Create E-mail Alert Related Categories
UpgradesRelated Entities
RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
